Eli Lilly And Company (LLY) Stock Declined While Lilly Endowment Has Decreased Stake by $34.02 Million; Lear (LEA) Holder Seminole Management Has Raised Holding by $616,000

April 26, 2018 - By Lawrence Diaz

Lear Corporation (NYSE:LEA) Logo

Lilly Endowment Inc decreased its stake in Eli Lilly And Company (LLY) by 0.33% based on its latest 2017Q4 regulatory filing with the SEC. Lilly Endowment Inc sold 405,000 shares as the company’s stock declined 11.06% with the market. The institutional investor held 123.08 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $10.39 billion, down from 123.48 million at the end of the previous reported quarter. Lilly Endowment Inc who had been investing in Eli Lilly And Company for a number of months, seems to be less bullish one the $84.55 billion market cap company. The stock increased 1.31% or $1.05 during the last trading session, reaching $81.14. About 5.38M shares traded or 8.48% up from the average. Eli Lilly and Company (NYSE:LLY) has declined 10.19% since April 26, 2017 and is downtrending. It has underperformed by 21.74% the S&P500.

Michael Messner increased its stake in Lear Corp (LEA) by 2.58% based on its latest 2017Q4 regulatory filing with the SEC. Seminole Management bought 3,500 shares as the company’s stock rose 4.15% while stock markets declined. The hedge fund run by Michael Messner held 139,111 shares of the o.e.m. company at the end of 2017Q4, valued at $24.58 million, up from 135,611 at the end of the previous reported quarter. Seminole Management who had been investing in Lear Corp for a number of months, seems to be bullish on the $12.49 billion market cap company. The stock increased 0.05% or $0.1 during the last trading session, reaching $188.49. About 489,796 shares traded. Lear Corporation (NYSE:LEA) has risen 33.95% since April 26, 2017 and is uptrending. It has outperformed by 22.40% the S&P500.

Among 22 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Eli Lilly and Company had 102 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Sell” rating by BMO Capital Markets given on Wednesday, August 30. The rating was upgraded by Deutsche Bank on Monday, December 7 to “Buy”. The firm has “Buy” rating given on Thursday, August 27 by Berenberg. Jefferies maintained the stock with “Buy” rating in Thursday, June 22 report. Jefferies maintained the shares of LLY in report on Tuesday, March 15 with “Buy” rating. On Monday, June 5 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by Bank of America with “Neutral” on Thursday, February 1. SunTrust maintained it with “Buy” rating and $101.0 target in Friday, October 27 report. Jefferies maintained Eli Lilly and Company (NYSE:LLY) rating on Friday, September 18. Jefferies has “Buy” rating and $115.0 target. On Friday, October 13 the stock rating was maintained by Barclays Capital with “Overweight”.

Since December 11, 2017, it had 0 insider purchases, and 8 selling transactions for $21.75 million activity. On Friday, April 13 Mahony Susan sold $1.81 million worth of Eli Lilly and Company (NYSE:LLY) or 22,544 shares. Smiley Joshua L had sold 3,000 shares worth $237,600 on Friday, March 16. Shares for $65,790 were sold by Zakrowski Donald A. Simmons Jeffrey N had sold 9,625 shares worth $780,780 on Thursday, February 1.

Investors sentiment increased to 1.1 in Q4 2017. Its up 0.21, from 0.89 in 2017Q3. It increased, as 42 investors sold LLY shares while 380 reduced holdings. 117 funds opened positions while 346 raised stakes. 827.08 million shares or 0.09% less from 827.83 million shares in 2017Q3 were reported. Gideon Capital Advisors Incorporated holds 0.48% of its portfolio in Eli Lilly and Company (NYSE:LLY) for 6,410 shares. Navellier And Inc has 3,512 shares for 0.06% of their portfolio. Sumitomo Mitsui Trust Holding has invested 0.32% of its portfolio in Eli Lilly and Company (NYSE:LLY). State Board Of Administration Of Florida Retirement System invested 0.31% in Eli Lilly and Company (NYSE:LLY). Moreover, Clearbridge Investments Ltd Liability Company has 0% invested in Eli Lilly and Company (NYSE:LLY) for 7,848 shares. First State Bank Tru Of Newtown has 0.12% invested in Eli Lilly and Company (NYSE:LLY). Van Cleef Asset Managementinc has invested 0.11% in Eli Lilly and Company (NYSE:LLY). Cap One Natl Association reported 0.15% in Eli Lilly and Company (NYSE:LLY). 18,085 were accumulated by Walleye Trading Ltd Limited Liability Company. Dumont Blake Inv Advisors Lc invested in 7,550 shares. Menta Ltd reported 14,007 shares. Willis Counsel holds 231,581 shares or 1.37% of its portfolio. Private Ocean Limited Liability Corporation invested in 1,049 shares. Dorsey Whitney Tru Com accumulated 49,211 shares or 0.77% of the stock. Public Employees Retirement Of Ohio has 0.28% invested in Eli Lilly and Company (NYSE:LLY).

Since February 16, 2018, it had 0 insider buys, and 10 insider sales for $46.04 million activity. Shares for $190,671 were sold by RUNKLE DONALD L. The insider DiDonato Thomas A sold 21,415 shares worth $4.07M. $4.33M worth of Lear Corporation (NYSE:LEA) was sold by Larkin Terrence B. On Friday, February 16 the insider SCOTT RAYMOND E sold $4.86 million. Shares for $3.28 million were sold by STEPHENS MEL. Kunkel Jay K. also sold $1.27M worth of Lear Corporation (NYSE:LEA) shares.

Seminole Management, which manages about $3.29 billion and $548.56 million US Long portfolio, decreased its stake in American Express Co (NYSE:AXP) by 153,926 shares to 581,581 shares, valued at $57.76M in 2017Q4, according to the filing. It also reduced its holding in Bank Amer Corp (NYSE:BAC) by 76,219 shares in the quarter, leaving it with 1.98 million shares, and cut its stake in Magna Intl Inc (NYSE:MGA).

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>